Galenica (XSWX:GALE) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALE Galenica Ltd XSWX:GALE
82 GF Score
Price CHF87.15
GF Value CHF86.57
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica 3-Month Share Buyback Ratio?

Galenica XSWX:GALE +0.52% 82 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates XSWX:GALE with a GF Score™ of 82/100 and a GF Value™ of CHF86.57 (Fairly Valued). The stock has 1 warning sign investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

XSWX:GALE
82GF Score
Galenica Ltd XSWX:GALE
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Galenica (XSWX:GALE) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Galenica and its competitors.
Is Galenica's 3-Month Share Buyback Ratio too high?
Galenica's current 3-Month Share Buyback Ratio is 0.00. Overall, Galenica has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's 3-Month Share Buyback Ratio compare to MCK and COR?
Galenica's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Distribution company?
A good 3-Month Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Galenica and its competitors. Galenica's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (XSWX:GALE) is currently considered Fairly Valued. The stock's GF Value™ is CHF86.57, compared to a current price of CHF87.15 — trading 0.7% above its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Galenica's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Galenica (XSWX:GALE), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (XSWX:GALE) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be overvalued. The current stock price of CHF87.15 is trading 0.7% above its estimated GF Value™ of CHF86.57. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for XSWX:GALE:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: CHF86.57 vs. price of CHF87.15 (0.7% above fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the XSWX:GALE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
82GF Score

Get the complete analysis for XSWX:GALE

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF87.15
Price
CHF86.57
GF Value